18M6 Stock Overview
Amundi ETF MSCI Europe Healthcare UCITS ETF is an exchange traded fund launched and managed by Amundi Asset Management.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Amundi ETF MSCI Europe Healthcare UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €394.30 |
52 Week High | €402.80 |
52 Week Low | €344.25 |
Beta | 0 |
1 Month Change | 1.34% |
3 Month Change | 8.21% |
1 Year Change | 12.77% |
3 Year Change | 36.37% |
5 Year Change | 56.50% |
Change since IPO | 294.58% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
18M6 | DE Capital Markets | DE Market | |
---|---|---|---|
7D | 0.4% | 2.6% | 1.6% |
1Y | 12.8% | 21.0% | 6.4% |
Return vs Industry: 18M6 underperformed the German Capital Markets industry which returned 21% over the past year.
Return vs Market: 18M6 exceeded the German Market which returned 6.4% over the past year.
Price Volatility
18M6 volatility | |
---|---|
18M6 Average Weekly Movement | 1.7% |
Capital Markets Industry Average Movement | 4.2% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 18M6 has not had significant price volatility in the past 3 months.
Volatility Over Time: 18M6's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | n/a | n/a |
Amundi ETF MSCI Europe Healthcare UCITS ETF is an exchange traded fund launched and managed by Amundi Asset Management. The fund invests in the public equity markets of developed markets in Europe. It uses derivatives such as swaps to invest in stocks of companies operating in the health care sector.
Amundi ETF MSCI Europe Healthcare UCITS ETF Fundamentals Summary
18M6 fundamental statistics | |
---|---|
Market cap | n/a |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 18M6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
18M6 income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did 18M6 perform over the long term?
See historical performance and comparison